Bristol Myers Squibb (BMY) Dividends payables (QoQ) (2009 - 2015)

Bristol Myers Squibb (BMY) Dividends payables (QoQ) (2009 - 2015) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Dec 31, 2015 2.99%
Sep 30, 2015 0.32%
Jun 30, 2015 0.16%
Mar 31, 2015 -1.86%
Dec 31, 2014 3.53%
Sep 30, 2014 0.32%
Jun 30, 2014 0.32%
Mar 31, 2014 -2.37%
Dec 31, 2013 3.76%
Sep 30, 2013 0.83%
Jun 30, 2013 0.83%
Mar 31, 2013 -0.83%
Dec 31, 2012 1.68%
Sep 30, 2012 -0.33%
Jun 30, 2012 0.84%
Mar 31, 2012 -0.67%
Dec 31, 2011 3.29%
Sep 30, 2011 -0.17%
Jun 30, 2011 0.17%
Mar 31, 2011 0.52%